Techniques and Strategies in Drug Design and Discovery, 2nd Edition
Deadline for manuscript submissions: 30 March 2024 | Viewed by 1840
Interests: the design and synthesis of new anticancer agents; the design and synthesis of new antimicrobial compounds; studies and structural analysis; the isolation and analysis of natural compounds with anticancer effects; computer-assisted drug design studies
Special Issues, Collections and Topics in MDPI journals
Drug discovery is a very complex and difficult process that involves finding and developing novel therapeutic entities. In recent years, the methodology behind drug discovery has rapidly evolved and comprises a plethora of paradigms and techniques, but there remains no perfect algorithm for guaranteed success. Despite considerable research, fortunate discoveries and the incredible intuition, inspiration, and creativity of researchers still play a vital role in the field of drug discovery, which remains popular among many scientists. Novel approaches and innovations are needed to address the dominant challenge of cost efficiency. In light of this challenge, novel approaches and innovations are imperative. To address this pressing issue, we are pleased to announce the continuation of our previous Special Issue, which is dedicated to serving as a comprehensive platform for researchers working in this field. This Special Issue provides an inclusive space for presenting recent efforts aimed at enhancing current methodologies and discovering new molecular entities. We welcome innovative research contributions, as well as insightful reviews of existing practices, in all facets of drug discovery and drug development.
In the first edition, eight papers were published; we sincerely welcome you to read these papers and contribute to this 2nd edition. We believe that through collaborative efforts and the exchange of knowledge in this Special Issue, we can drive significant advancements in drug discovery and ultimately improve global healthcare outcomes.
Prof. Dr. George Mihai Nitulescu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug discovery
- drug development
- target identification
- computational drug design
- structure-based drug design
- ligand-based drug design